Investors are keeping a close eye on RLX Technology Inc. (NYSE:RLX) as Nuveen LLC recently took a significant position in the company. With a $597,000 investment in the first quarter, Nuveen joins a growing list of institutional investors showing confidence in the future of this e-vapor industry leader. For shareholders and market watchers, this move highlights the potential for RLX Technology to continue attracting attention from both Wall Street and international investors.
Nuveen LLC’s Stake in RLX Technology
Nuveen LLC acquired 317,500 shares of RLX Technology during the first quarter, according to recent SEC filings. Valued at approximately $597,000, this investment underscores the firm’s belief in RLX’s growth trajectory and long-term prospects in the competitive e-vapor market.
RLX Technology, headquartered in Beijing, China, specializes in the manufacturing and sale of e-vapor products, serving both domestic and international distributors. Founded in 2018, the company has rapidly expanded its footprint, attracting institutional investors seeking exposure to this emerging market.
Other Institutional Moves
Several other hedge funds and investment firms have also adjusted their positions in RLX Technology. HSBC Holdings PLC increased its stake by 10.6%, now owning 198,832 shares valued at $429,000. Northern Trust Corp significantly boosted its holdings by 56.6% to 862,499 shares worth $1.86 million. Bank of America Corp DE and Cubist Systematic Strategies LLC also increased their positions, demonstrating broad interest from institutional investors.
Currently, institutional investors and hedge funds collectively own 22.68% of RLX Technology’s stock, signaling strong backing from financial professionals.
RLX Technology’s Stock Performance and Market Metrics

RLX stock opened at $2.54 on Thursday, with a 52-week low of $1.57 and a high of $2.69. The stock’s 50-day moving average stands at $2.29, while the 200-day moving average is $2.12. With a market capitalization of $3.98 billion, a PE ratio of 36.22, and a beta of 1.10, RLX Technology continues to demonstrate stability despite volatile market conditions.
Recent Financial Performance
In its quarterly earnings report released on August 22nd, RLX Technology posted earnings per share (EPS) of $0.02, falling short of the consensus estimate of $0.18. Revenue for the quarter reached $122.88 million, significantly below analysts’ expectations of $725 million. The company reported a return on equity of 4.54% and a net margin of 22.32%, highlighting both challenges and opportunities in scaling operations.
Dividend Announcement
RLX Technology recently declared an annual dividend of $0.01 per share, with shareholders of record on September 12th eligible to receive payment on September 26th. This represents a yield of 70.0% and a payout ratio of 14.29%, offering investors a modest return while retaining capital for growth initiatives.
Analyst Ratings and Market Outlook

Analysts have provided mixed guidance on RLX shares. Citigroup recently reduced its price target from $2.50 to $2.25, maintaining a “neutral” rating. Meanwhile, Wall Street Zen upgraded RLX from a “sell” rating to a “hold” rating. Currently, the company maintains an average “Hold” rating with a consensus target price of $2.25.
Why Investors Are Watching RLX Technology
RLX Technology operates in a rapidly evolving global market for e-vapor products, offering growth potential for strategic investors. Nuveen LLC’s new stake reflects a belief in the company’s long-term prospects, while other institutional investors continue to adjust positions based on market trends and regulatory developments in China and abroad.
The company’s focus on international expansion and partnerships with distributors positions RLX to leverage growth opportunities in both emerging and established markets. For investors, monitoring RLX’s earnings performance, dividend payments, and institutional activity is key to assessing potential returns.
Frequently Asked Questions (FAQs)
- What recent investment did Nuveen LLC make in RLX Technology?
Nuveen LLC acquired 317,500 shares of RLX Technology, valued at approximately $597,000 in the first quarter. - Who are other major institutional investors in RLX Technology?
HSBC Holdings PLC, Northern Trust Corp, Bank of America Corp DE, Bayesian Capital Management LP, and Cubist Systematic Strategies LLC all hold significant stakes in the company. - What is RLX Technology’s current stock price and market cap?
RLX stock opened at $2.54, with a market capitalization of $3.98 billion. The stock’s 52-week range is $1.57 to $2.69. - Did RLX Technology report positive earnings recently?
RLX posted an EPS of $0.02, missing the consensus estimate of $0.18, with quarterly revenue of $122.88 million. - What is the company’s dividend policy?
RLX Technology declared an annual dividend of $0.01 per share, with a yield of 70.0% and a payout ratio of 14.29%.
Conclusion: Nuveen LLC’s investment in RLX Technology highlights continued confidence in the company’s growth and potential in the e-vapor sector. As institutional investors adjust their holdings and the company expands internationally, RLX Technology remains a stock to watch. For investors seeking exposure to the evolving e-vapor market, tracking RLX’s earnings, dividends, and institutional activity is essential.
Disclaimer: This article is based on publicly available financial disclosures and market reports. It is intended for informational purposes only and does not constitute financial advice or a recommendation to buy or sell securities.